HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsing-Pang Hsieh Selected Research

CHR 8

1/2021Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsing-Pang Hsieh Research Topics

Disease

39Neoplasms (Cancer)
05/2024 - 06/2002
8Infections
09/2022 - 07/2004
8Human Influenza (Influenza)
01/2013 - 01/2007
4Neoplasm Metastasis (Metastasis)
05/2024 - 06/2010
4Leukemia
01/2022 - 07/2010
3Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2009
3Carcinogenesis
01/2011 - 03/2009
2Prostatic Neoplasms (Prostate Cancer)
05/2022 - 07/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 06/2008
2Melanoma (Melanoma, Malignant)
01/2019 - 02/2007
2Carcinoma (Carcinomatosis)
05/2018 - 07/2004
2Colonic Neoplasms (Colon Cancer)
11/2017 - 07/2013
2Lung Neoplasms (Lung Cancer)
06/2017 - 07/2010
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2016 - 06/2015
2Virus Diseases (Viral Diseases)
02/2010 - 01/2006
2Genomic Instability
04/2009 - 03/2009
2Severe Acute Respiratory Syndrome
06/2006 - 07/2004
1COVID-19
09/2022
1Epilepsy (Aura)
10/2021
1Kidney Calculi (Kidney Stone)
07/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2017
1Polyploidy
08/2014

Drug/Important Bio-Agent (IBA)

8Aurora KinasesIBA
01/2022 - 03/2009
8Phosphotransferases (Kinase)IBA
01/2020 - 01/2007
5Antiviral Agents (Antivirals)IBA
09/2022 - 07/2004
56- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indoleIBA
01/2013 - 07/2004
4TubulinIBA
01/2013 - 07/2009
4Neuraminidase (Sialidase)IBA
01/2013 - 01/2007
4DNA (Deoxyribonucleic Acid)IBA
07/2009 - 05/2005
3cathepsin SIBA
05/2024 - 06/2010
3Antineoplastic Agents (Antineoplastics)IBA
07/2021 - 07/2004
3Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 09/2010
3Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 07/2009
3Proteins (Proteins, Gene)FDA Link
05/2013 - 01/2007
3Antimitotic AgentsIBA
01/2013 - 07/2004
2Cysteine Proteases (Cysteine Protease)IBA
05/2024 - 12/2019
2VaccinesIBA
09/2022 - 07/2021
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
05/2022 - 01/2013
2fms-Like Tyrosine Kinase 3IBA
01/2022 - 06/2015
2EnzymesIBA
03/2021 - 01/2021
2piperineIBA
01/2021 - 11/2017
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021 - 11/2017
2QuinazolinesIBA
01/2020 - 12/2016
2ErbB Receptors (EGF Receptor)IBA
11/2019 - 06/2008
2Viral RNAIBA
12/2014 - 01/2010
2Aurora Kinase AIBA
08/2014 - 05/2013
2Cisplatin (Platino)FDA LinkGeneric
07/2010 - 07/2009
2Peptide Hydrolases (Proteases)FDA Link
06/2010 - 06/2006
2Zanamivir (Relenza)FDA Link
02/2010 - 01/2007
2Oseltamivir (Tamiflu)FDA Link
01/2010 - 01/2007
2CaspasesIBA
07/2009 - 07/2004
22,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanoneIBA
07/2004 - 06/2003
2fosbretabulin (combretastatin A4)IBA
01/2003 - 06/2002
1AntibodiesIBA
09/2022
1Neutralizing AntibodiesIBA
09/2022
1AndrogensIBA
05/2022
1enzalutamideIBA
05/2022
1Histone DemethylasesIBA
05/2022
1myricetinIBA
05/2022
1Androgen Receptors (Androgen Receptor)IBA
05/2022
1dolutegravirIBA
04/2022
1etravirine (TMC-125)FDA Link
04/2022
1regorafenibIBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1Mesylates (Mesylate)IBA
10/2021
1Aurora Kinase BIBA
10/2021
1SolventsIBA
07/2021
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
07/2021
1MicellesIBA
07/2021
1AntigensIBA
07/2021
1monomethoxypolyethyleneglycol- polylactide block copolymerIBA
07/2021
1MethyltransferasesIBA
03/2021
1Protein MethyltransferasesIBA
03/2021
1Arginine (L-Arginine)FDA Link
03/2021
1Lysine (L-Lysine)FDA Link
03/2021
1Cytochrome P-450 CYP3AIBA
01/2021
1CHR 8IBA
01/2021
1acteosideIBA
08/2020
1UromodulinIBA
07/2020
1Serine Proteases (Serine Protease)IBA
07/2020
1hepsinIBA
07/2020
1Messenger RNA (mRNA)IBA
01/2020
1RNA IsoformsIBA
01/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1locked nucleic acidIBA
01/2020
11,2,4-triazoleIBA
01/2019
1ColchicineFDA LinkGeneric
11/2017
1bcr-abl Fusion ProteinsIBA
06/2017
1Gefitinib (Iressa)FDA Link
06/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2017
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
12/2014
1Tyrosine Kinase InhibitorsIBA
10/2014
1Tyrosine (L-Tyrosine)FDA Link
10/2014

Therapy/Procedure

18Therapeutics
09/2022 - 01/2006
2Oral Administration
01/2023 - 10/2021
1Castration
05/2022
1Immunotherapy
10/2021
1Precision Medicine
11/2019
1Drug Therapy (Chemotherapy)
06/2015